Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406952 · ClinicalTrials.gov registry record · NA
Study for Evaluating Different Methods of Measuring Depression Treatment Response
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 165
- Enrollment target
NCT00406952 is a NA study that has completed, run by Pfizer. The registered enrollment target is 165 participants.
The verdict
NCT00406952, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
Study Summary
Purpose of the study is to evaluate use of electronic diaries and voice acoustics for use in future depression clinical trial. Focus is on increased precision of measurement.
Interventions
- DRUG Placebo
- DRUG Sertraline
- PROCEDURE electronic diary
- PROCEDURE voice acoustics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00406952
The ClinicalTrials.gov registry entry for NCT00406952 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00406952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00406952 about?
NCT00406952 is a clinical study titled "Study for Evaluating Different Methods of Measuring Depression Treatment Response". Purpose of the study is to evaluate use of electronic diaries and voice acoustics for use in future depression clinical trial. Focus is on increased precision of measurement.
What is the current status of trial NCT00406952?
This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2006-11. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00406952?
The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG), electronic diary (PROCEDURE), voice acoustics (PROCEDURE).
Who is sponsoring clinical trial NCT00406952?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.